Company Statement: Crucell - Discussions on a combination of Crucell and Wyeth discontinued
Extract: Dutch biopharmaceutical company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) today announced that Wyeth has withdrawn from discussions regarding a potential combination of the two companies.Leiden, The Netherlands- Dutch...To view the full article, register now.
Already a subscriber? Click here to view full article